Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,112.20 -206.04 -1.35%
S&P 500 1,628.93 -22.88 -1.39%
Nasdaq 3,443.20 -38.98 -1.12%
Ticker Volume Price Price Delta
STOXX 50 2,683.98 -16.95 -0.63%
FTSE 100 6,348.82 -25.39 -0.40%
DAX 8,197.08 -32.43 -0.39%
Ticker Volume Price Price Delta
Nikkei 13,245.20 +237.94 1.83%
Hang Seng 20,986.90 -238.99 -1.13%
S&P/ASX 200 4,861.38 +47.03 0.98%
  • Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Health Care Supplies

Trauson Holdings Co Ltd

+ Add to Watchlist

325:HK

7.460 HKD 0.0000.00%

As of 04:01:08 ET on 06/19/2013.

Trading has been suspended for 325:HK

Snapshot for Trauson Holdings Co Ltd (325)

Open: 7.460 Day's Range: 7.460 - 7.460 Volume: 0
Previous Close: 7.460 52wk Range: 2.544 - 7.480 1-Yr Rtn: +184.76%

Stock Chart for 325

No chart data available.
  • 325:HK 7.460
  • 1D
  • 1M
  • 1Y
7.460
Interactive 325 Chart

Previous Close

Key Statistics for 325

Current P/E Ratio (ttm) 29.4602
Estimated P/E(12/2012) 25.3989
Relative P/E vs. HSI 3.0784
Earnings Per Share (CNY) (ttm) 0.2000
Est. EPS (CNY) (12/2012) 0.2320
Est. PEG Ratio -
Market Cap (M HKD) 5,776.49
Shares Outstanding (M) 774.33
30 Day Average Volume 0
Price/Book (mrq) 4.5204
Price/Sale (ttm) 10.6031
Dividend Indicated Gross Yield 0.98%
Cash Dividend (CNY) 0.0217
Last Dividend 09/14/2012
5 Year Dividend Growth -
Next Earnings Announcement 08/15/2013
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 325

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 325

Trauson Holdings Company Ltd. manufactures orthopedic products. The Company designs, manufactures and markets products used in the surgical treatment of fractures of the hands, upper extremities, hips, pelvis, lower extremities, ankles and feet, spinal disorders, deformity, fractures and back pain, and orthopedic cables, external fixators and surgical instruments.

Ramesh SubrahmanianChairman/Executive DirectorAiguo WangCEO/Executive Director
Vincenzo RispoliExecutive DirectorTony M McKinneyExecutive Director
More Company Profile & Key Executives for 325

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil